EP. 1: Mutation Testing for NSCLC in 2017
EP. 2: Options for Up-front Therapy in EGFR-mutant NSCLC
EP. 3: Efficacy and Safety of Afatinib vs Erlotinib and Gefitinib in EGFR+ NSCLC
EP. 4: Sequencing EGFR-Targeted Therapies in NSCLC
EP. 5: Tolerability-Guided Dose Adjustment of Afatinib in NSCLC
Oncology Experts Preview Top Abstracts From 2025 ASCO GU
Dr Somaiah on Ongoing Research With Novel Agents in Sarcomas
Dr Hamid on the Potential for Cancer Vaccines in Melanoma
Dr Orloff on Treatment Strategies for Rapidly Progressing Uveal Melanoma